Licia Bordi
- Infectious Diseases top 1%
- Viral Infections and Vectors 19
- SARS-CoV-2 and COVID-19 Research 17
- SARS-CoV-2 detection and testing 12
- Viral gastroenteritis research and epidemiology 9
- COVID-19 Clinical Research Studies 7
- Virology top 5%
- Modeling and Simulation top 5%
-
- Mosquito-borne diseases and control 18
- Epidemiology top 10%
- Respiratory viral infections research 10
- Influenza Virus Research Studies 9
- Co-authors
- Maria Rosaria CapobianchiConcetta CastillettiEleonora LalleGiuseppe IppolitoFrancesca ColavitaFabrizio CarlettiClaudia CagliotiAntonino Di
- Journals
- PLoS ONE (3 papers)International Journal of Molecular Sciences (2 papers)Journal of Clinical Microbiology (2 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Licia Bordi
72 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 114
- Infectious Diseases 1.2k
- Virology 122
- Modeling and Simulation 98
- Public Health, Environmental and Occupational Health 577
- Epidemiology 450
Countries citing papers authored by Licia Bordi
This map shows the geographic impact of Licia Bordi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Licia Bordi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Licia Bordi more than expected).
Fields of papers citing papers by Licia Bordi
This network shows the impact of papers produced by Licia Bordi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Licia Bordi. The network helps show where Licia Bordi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Licia Bordi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 15 | |
| 9 | 2021 | 20 | |
| 10 | 2021 | 18 | |
| 11 | 2021 | 40 | |
| 12 | 2020 | 57 | |
| 13 | 2020 | 13 | |
| 14 | 2020 | 61 | |
| 15 | 2020 | 66 | |
| 16 | 2019 | 92 | |
| 17 | 2018 | 18 | |
| 18 | 2015 | 10 | |
| 19 | Type III interferon (IFN-lambda) antagonizes the antiviral activity of interferon-alpha in vitro. | 2014 | 5 |
| 20 | In vivo Studies of the Non-transcribed Spacer Region of rDNA in Saccharomyces cerevisiae | 2000 | 1 |
About Licia Bordi
Licia Bordi is a scholar working on Infectious Diseases, Virology and Modeling and Simulation, having authored 74 papers that have together received 1.8k indexed citations. Recurring topics across this work include Viral Infections and Vectors (19 papers), Mosquito-borne diseases and control (18 papers), SARS-CoV-2 and COVID-19 Research (17 papers), SARS-CoV-2 detection and testing (12 papers), Respiratory viral infections research (10 papers), Influenza Virus Research Studies (9 papers), Viral gastroenteritis research and epidemiology (9 papers) and COVID-19 Clinical Research Studies (7 papers). The work is most often cited by research in Infectious Diseases (1.2k citations), Virology (122 citations) and Modeling and Simulation (98 citations). Licia Bordi has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Maria Rosaria Capobianchi, Concetta Castilletti, Eleonora Lalle, Giuseppe Ippolito, Francesca Colavita, Fabrizio Carletti, Claudia Caglioti, Antonino Di, Silvia Meschi and Giulia Matusali. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.